Towards the first antibody-free serum biomarker assay for NAFLD

Towards the first antibody-free serum biomarker assay for NAFLD

Show other versions (1)

Liver biopsy is the reference standard for NAFLD diagnosis and staging. NAFLD can be assessed less invasively using immunoassays to detect serum biomarkers. However, biomarkers can degrade due to sample storage conditions and therefore may not be detected using these antibody-based assays. Detection...

Full description

Bibliographic Details
Main Authors:	Gangadharan, B, Kumar, A, Cobbold, J, Thursz, M, Dwek, RA, Zitzmann, N
Format:	Conference item
Published:	OMICS International 2017

Similar Items

Towards the first antibody-free serum biomarker assay for NAFLD
by: Gangadharan, B, et al.
Published: (2017)

Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example
by: Kumar, A, et al.
Published: (2017)

Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
by: Gangadharan, B, et al.
Published: (2012)

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
by: Gangadharan, B, et al.
Published: (2008)

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2007)

LC-MS based discovery of novel protein biomarkers and their quantitation in HCV fibrosis and NASH diseased human serum
by: Kumar, A, et al.
Published: (2014)

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
by: Gangadharan, B, et al.
Published: (2010)

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
by: Gangadharan, B, et al.
Published: (2016)

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
by: Gangadharan, B, et al.
Published: (2016)

Two dimensional gel electrophoresis using narrow pH 3-5.6 immobilised pH gradient strips identifies potential novel disease biomarkers in plasma or serum
by: Gangadharan, B, et al.
Published: (2011)

Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders
by: Andrey Turchinovich, et al.
Published: (2018-09-01)

Multiple reaction monitoring and multiple reaction monitoring cubed based assay for the quantitation of apolipoprotein F
by: Kumar, A, et al.
Published: (2016)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
by: Tina Reinson, et al.
Published: (2023-02-01)

New proteomics approaches for discovering biomarkers: Searching for liver fibrosis markers in hepatitis c patients
by: Gangadharan, B, et al.
Published: (2012)

Hepatic iron is the major determinant of serum ferritin in NAFLD patients.
by: Ryan, J, et al.
Published: (2017)

NAFLD: Mechanisms, Treatments, and Biomarkers
by: Fatiha Nassir
Published: (2022-06-01)

Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum.
by: Pardo, M, et al.
Published: (2006)

Comparison between NAFLD fibrosis score and retinoic acid serum level in NAFLD
by: Ahmed Samir Allam, et al.
Published: (2020-01-01)

Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
by: Pardo, M, et al.
Published: (2007)

Imaging biomarkers of NAFLD, NASH, and fibrosis
by: Veeral Ajmera, et al.
Published: (2021-08-01)

PTH-092 Discovery and quantitation of novel liver fibrosis biomarkers using proteomics
by: Gangadharan, B, et al.
Published: (2015)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2011)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2011)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients using proteomics
by: Gangadharan, B, et al.
Published: (2014)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2014)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
by: Gangadharan, B, et al.
Published: (2016)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study
by: Gangadharan, B, et al.
Published: (2012)

Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
by: Stefania Di Mauro, et al.
Published: (2021-11-01)

T2*magnetic resonance imaging is more sensitive than histology and serum ferritin for the assessment of iron overload in patients with NAFLD
by: Pavlides, M, et al.
Published: (2014)

The correlation between NAFLD and serum uric acid to serum creatinine ratio.
by: Jangwon Choi, et al.
Published: (2023-01-01)

A rapid solid-phase enzyme-linked binding assay for screening monoclonal antibodies to cell surface antigens.
by: Cobbold, S, et al.
Published: (1981)

The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker.
by: Pardo, M, et al.
Published: (2006)

Correction: The Correlation Between NAFLD and Serum Uric Acid to Serum Creatinine Ratio.
by: Jangwon Choi, et al.
Published: (2023-01-01)

Correction: The Correlation Between NAFLD and Serum Uric Acid to Serum Creatinine Ratio
Published: (2023-01-01)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
by: Bevin Gangadharan, et al.
Published: (2012-01-01)

Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients
by: Reine Kanaan, et al.
Published: (2023-03-01)

COMPARISON OF SERUM FERRITIN LEVELS IN NAFLD PATIENTS AND HEALTHY CONTROLS
by: Mehwish Qamar, et al.
Published: (2020-12-01)

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD
by: Xuelian Xiong
Published: (2023-09-01)

Development and validation of an automated assay for anti-drug-antibodies in rat serum
by: Kristy A. Terrell, et al.
Published: (2023-10-01)

Development of Assay for Determining Free IgE Levels in Serum from Patients Treated with Omalizumab
by: Reiko Ito, et al.
Published: (2014-01-01)